American International Group, Inc. Enanta Pharmaceuticals Inc Transaction History

American International Group, Inc.

  • $8.5 Billion
  • Q3 2024

Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

May 13, 2024
BUY
$10.08 - $17.46 $433 - $750
43 Added 0.43%
9,985 $174,000
Q4 2023

Feb 13, 2024
SELL
$8.18 - $10.78 $327 - $431
-40 Reduced 0.4%
9,942 $93,000
Q3 2023

Nov 13, 2023
SELL
$11.09 - $22.13 $8,273 - $16,508
-746 Reduced 6.95%
9,982 $111,000
Q2 2023

Aug 04, 2023
SELL
$20.68 - $39.85 $2,709 - $5,220
-131 Reduced 1.21%
10,728 $229,000
Q1 2023

May 12, 2023
BUY
$38.82 - $54.59 $8,618 - $12,118
222 Added 2.09%
10,859 $439,000
Q4 2022

Feb 10, 2023
SELL
$40.77 - $53.73 $3,383 - $4,459
-83 Reduced 0.77%
10,637 $494,000
Q3 2022

Nov 14, 2022
BUY
$48.29 - $71.27 $9,368 - $13,826
194 Added 1.84%
10,720 $556,000
Q2 2022

Aug 12, 2022
SELL
$38.13 - $76.93 $22,572 - $45,542
-592 Reduced 5.32%
10,526 $498,000
Q1 2022

May 13, 2022
SELL
$56.06 - $74.11 $27,973 - $36,980
-499 Reduced 4.3%
11,118 $791,000
Q4 2021

Feb 11, 2022
SELL
$60.19 - $97.37 $22,330 - $36,124
-371 Reduced 3.09%
11,617 $869,000
Q3 2021

Nov 12, 2021
SELL
$41.02 - $58.65 $16,695 - $23,870
-407 Reduced 3.28%
11,988 $681,000
Q2 2021

Aug 13, 2021
SELL
$43.76 - $53.11 $13,915 - $16,888
-318 Reduced 2.5%
12,395 $546,000
Q1 2021

May 07, 2021
SELL
$41.69 - $54.95 $125 - $164
-3 Reduced 0.02%
12,713 $627,000
Q4 2020

Feb 12, 2021
SELL
$41.16 - $47.47 $13,212 - $15,237
-321 Reduced 2.46%
12,716 $535,000
Q3 2020

Nov 04, 2020
SELL
$43.36 - $53.53 $6,980 - $8,618
-161 Reduced 1.22%
13,037 $597,000
Q2 2020

Aug 12, 2020
BUY
$46.37 - $57.58 $18,687 - $23,204
403 Added 3.15%
13,198 $663,000
Q1 2020

May 04, 2020
BUY
$40.22 - $62.0 $20,833 - $32,116
518 Added 4.22%
12,795 $658,000
Q4 2019

Feb 05, 2020
SELL
$57.95 - $66.61 $18,080 - $20,782
-312 Reduced 2.48%
12,277 $758,000
Q3 2019

Nov 08, 2019
SELL
$60.08 - $88.17 $8,230 - $12,079
-137 Reduced 1.08%
12,589 $756,000
Q2 2019

Aug 13, 2019
BUY
$81.3 - $97.35 $15,203 - $18,204
187 Added 1.49%
12,726 $1.07 Million
Q1 2019

May 06, 2019
SELL
$69.08 - $105.66 $23,625 - $36,135
-342 Reduced 2.66%
12,539 $1.2 Million
Q4 2018

Feb 13, 2019
SELL
$65.41 - $84.65 $9,484 - $12,274
-145 Reduced 1.11%
12,881 $912,000
Q3 2018

Nov 09, 2018
BUY
$85.46 - $126.37 $33,585 - $49,663
393 Added 3.11%
13,026 $1.11 Million
Q2 2018

Aug 08, 2018
BUY
$81.85 - $120.51 $221,977 - $326,823
2,712 Added 27.34%
12,633 $1.46 Million
Q1 2018

May 07, 2018
SELL
$57.91 - $92.15 $131,224 - $208,811
-2,266 Reduced 18.59%
9,921 $803,000
Q4 2017

Feb 09, 2018
BUY
$45.65 - $59.37 $2,191 - $2,849
48 Added 0.4%
12,187 $715,000
Q3 2017

Nov 09, 2017
BUY
$37.91 - $46.8 $460,189 - $568,105
12,139
12,139 $568,000

Others Institutions Holding ENTA

# of Institutions
110
Shares Held
21.1M
Call Options Held
4.8K
Put Options Held
4.6K
View Full List

About ENANTA PHARMACEUTICALS INC

ENTA Quotes by TradingView
  • Ticker ENTA
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 20,724,900
  • Market Cap $194M
  • Description
  • Enanta Pharmaceuticals, Inc., a biotechnology company, discovers and develops small molecule drugs for the treatment of viral infections and liver diseases. Its research and development disease targets include respiratory syncytial virus, SARS-CoV-2, human metapneumovirus, and hepatitis B virus. The company has a collaborative development and li...
More about ENTA
Track This Portfolio

Track American International Group, Inc. Portfolio

Follow American International Group, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of American International Group, Inc., based on Form 13F filings with the SEC.

News

Stay updated on American International Group, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email